Concerta
Product Images NDC 54868-4789

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Concerta (NDC 54868-4789). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (18 mg Tablet Label)

FDA Label Image

Principal Display Panel (36 mg Tablet Label)

The text is not-available.*

FDA Label Image

Principal Display Panel (54 mg Tablet Label)

This is a medication label for Concerta®, a drug used for the treatment of attention deficit hyperactivity disorder (ADHD). The medication comes in tablet form with two strengths, 5mg and 54mg. The label provides dosage instructions and warnings about possible side effects. The lot number and expiration date are also provided.*

FDA Label Image

Principal Display Panel (27 mg Tablet Label)

FDA Label Image

Chemical Structure (Concerta 01)

FDA Label Image

Figure 1 (Concerta 02)

This is a chart that shows the mean plasma methylphenidate concentration (in ng/mL) over time (in hours) for two different medications: Concerta (18mg capsules) and a 5mg immediate-release tablet of methylphenidate. The data is not complete as there are values missing on the x-axis after 28 hours.*

FDA Label Image

Figure 2 (Concerta 03)

Not-Available*

FDA Label Image

Figure 3 (Concerta 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.